OSE Immunotherapeutics
Business Services · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
22 Boulevard Benoni Goullin, Nantes, Pay...Phone Number
+33 228291010Website
www.ose-immuno.comRevenue
<$5 MillionStock Symbol
OSEIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About OSE Immunotherapeutics
Ose Immunotherapeutics, founded in 2012 and headquartered in Nantes, France, is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases.Explore more
OSE Immunotherapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OSE Immunotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
OSE Immunotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at OSE Immunotherapeutics
Earning: See what the market has to say on OSE Immunotherapeutics recently announced quarterly report
Check if OSE Immunotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if OSE Immunotherapeutics is spiking on competitors!
Product Launch: Get notified when OSE Immunotherapeutics launches new products
Click to see if OSE Immunotherapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once OSE Immunotherapeutics has new funding data
Recommended Actions
Find VP level buyers at OSE Immunotherapeutics
Find 3 more new buyers
Company Profile Activity
Activity Insights
OSE Immunotherapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
OSE Immunotherapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about OSE Immunotherapeutics.
OSE Immunotherapeutics financials insights
Gather financial insights about OSE Immunotherapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$9M
OSE Immunotherapeutics Tech Stack
A closer look at the technologies used by OSE Immunotherapeutics
See more technologies
Most Recent Scoops
Earnings
Earnings, Finance
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Promotion
Executive Move
Executive Moves, Promotion
Promotion
Executive Move
Executive Moves, Promotion
OSE Immunotherapeutics News & Media
OSE Immunotherapeutics SA (ORPOF) Discussion of Tedopi Immunotherapy Pipeline and Clinical Progress Across Oncology Indications Transcript
OSE Immunotherapeutics SA (ORPOF) Discussion of Tedopi Immunotherapy Pipeline and Clinical Progress Across Oncology Indications June 10, 2026 12:00 PM...Annual General Meeting on June 24, 2026 Procedures for obtaining preparatory documents for the General Meeting
Assemblée Générale Mixte du 24 juin 2026 Modalités de mise à disposition des documents préparatoires à l’AssembléeOSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration Document
OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration DocumentOSE Immunotherapeutics to Implement a Flexible Bridge Equity Financing
OSE Immunotherapeutics to Implement a Flexible Bridge Equity Financing
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OSE Immunotherapeutics
Sign Up For FreeTo access detailed company insights
Ose Immunotherapeutics, founded in 2012 and headquartered in Nantes, France, is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases.... Read More
